Background Chronic oral corticosteroid (C-OCS) use in asthma is an indicator of disease
severity, but its risk factors are largely unknown. Objective To describe patient characteristics …

Background Patients with poor asthma control may receive oral corticosteroid (OCS) therapy
despite the risk for adverse effects. Objective We assessed OCS use frequency and …

Background Systemic corticosteroids (SCS) may cause complications for patients with
asthma. Objective We sought to better understand the burden of SCS use in persistent …

Background Patterns and determinants of long‐term oral corticosteroid (OCS) use in asthma
and related morbidity and mortality are not well‐described. In a nationwide asthma cohort in …

Oral corticosteroids (OCS) are used to manage asthma exacerbations and severe,
uncontrolled asthma, but OCS use is associated with adverse effects. We aimed to describe …

Background Significant adverse effects (AEs) have been associated with continuous
exposure to oral corticosteroids (OCSs). The potential association with intermittent exposure …

Options to achieve oral corticosteroid (OCS)-sparing have been triggering increasing
interest since the 1970s because of the side-effects of OCSs, and this has now become …

Background Many patients with severe asthma require maintenance treatment with systemic
corticosteroids (SCSs) to control daily symptoms and prevent serious acute exacerbations …

Background: Oral corticosteroids (OCS) are a mainstay of asthma treatment. Their use
increases the risk of various corticosteroid-related adverse events, but the extent of risk is …

Systemic corticosteroid use to manage uncontrolled asthma and its associated healthcare
burden may account for important health-related adverse effects. We conducted a systematic …